Good afternoon, everyone and thank you for participating on today’s First Quarter 2022 Business Update Call for MusclePharm.
Joining us today is MusclePharm’s Chairman and CEO, Ryan Drexler; the company’s President and CFO, Sabina Rizvi.
Following prepared remarks, we will take your questions.
As a reminder, in order to ask a question, please go to the Investor Relations section of the company’s website at www.musclepharm.com and you will be able to submit your name and questions on the webcast link.
The discussion today will include forward-looking statements except for historical information herein, matters set forth on this call are forward-looking within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements about the company’s commercial progress, success of its strategic relationships and projections of future financial performance.
continue, identified anticipate, use plan, such intend, potential, and are as words should, word statements and such forecast, expand, predict, forward-looking that grow, estimate, project, to and forward-looking similar by variations are of the such hypothetical, will, expressions These and may, intended of identify could, believe, expect, statements.
in statements the the address activities, or developments, that company All or that may are statements, events future facts occur other forward-looking statements. of historical than will believes the anticipates or
statements experience, are are other the based based These on current believes expected factors made assumptions company appropriate on circumstances. and under the future developments that
subject uncertainties, a are control which statements of assumptions, company. the to many are of risks and beyond Such the number of
risks actual prove or anticipated underlying assumptions may results these by or those of should such materialize more indicated incorrect, uncertainties materially or vary from or statements. one forward-looking Should
undue speak they’re these investors to on forward-looking are date the reliance of which place statements, made. as not cautioned Accordingly, only
The any call should and and in Form current Form filings its company’s reports considered contents XX-K the of the statements Annual including factors quarterly reports with Securities including Commission, therein. and and Exchange X-K, on this on conjunction warnings, recent Form the risk XX-Q with Report cautionary on be contained
a otherwise. the expressly or new intentions as Furthermore, result events, after whether in disclaims to current assumptions of update any statements information, company call, publicly any this forward-looking changes future
the in GAAP non-GAAP release, the are including -- comparable our which the today’s is adjusted aid to understanding table certain measures. results quarter the XXXX announcing on business order the measures, a press reconciled to first company In most of company’s also presenting in performance, EBITDA,
evaluate EBITDA, to because operating to performance, well further EBITDA the that working believes uses to as supplement as capital meet measures GAAP adjusted a provides adjusted Management to future company's requirements. the as ability period-to-period information investor, useful management
company's the amortization depreciation non-cash company. measuring useful and performance of operations including the is stock-based in cash of charges, available compensation, exclusion and for The
MusclePharm, I the will turn now call of to the Ryan Drexler. CEO over
ahead. go Please,